DataMEDS AI MEDS 深 滬
已收盤 11-06 16:00:00 美东时间
1.18
-0.040
-3.28%
華盛通- 最 高1.2399
- 今 開1.20
- 成交量 11.62万股
- 最 低 1.13
- 昨 收 1.22
- 總市值 377.32万
- 52周最高 2228.00
- 市盈率 靜 --
- 換手率 3.63%
- 52周最低 0.8225
- 委 比 -40.61%
- 總股本 319.76万
- 歷史最高 2228.00
- 量 比 0.39
- 振 幅 9.01%
- 歷史最低 0.8225
- 每 手 1
- 風險率 1.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Datavault AI Fires CEO Nathaniel Bradley
Datavault AI Inc. (NASDAQ:DVLT) disclosed Thursday that its board removed CEO and President Nathaniel Bradley, effective Nov. 1, marking a leadership shake-up at the artificial intelligence company. The board also terminated Bradley’s employment. All directors except Bradley approved the decision. B...
11-06 18:42
DataMEDS AI Moves Into Growing Peptide Market
DataMEDS AI, Inc. (NASDAQ:MEDS) announced Monday that its subsidiary, Corexa Health, has entered into an agreement to commercially supply bulk drug substances and active pharmaceutical ingredients for six peptides. Corexa Pharmacy plans to begin dispensing compounded prescriptions for the six peptid...
11-03 01:10
DataMeds AI's Pharmacy Unit Corexa Health Enters Agreement For Commercial Supply Of Six Peptides Recommended By The FDA Pharmacy Compounding Advisory Committee; Intends To Start Distributing Prescriptions In November 2026
DataMEDS intends to leverage the Health Lives Here mobile application to help collect and report safety data, in accordance with U.S. Health and Human Services' (HHS) Enforcement Discretion Policy (EDP) published in the Federal Register on October 30, 2026. The U.S. compounding pharmacy market is ex...
11-02 19:06
DataMeds AI Signs LoI To Acquire Portion Of Quality Of Life Peace Of Mind IP Portfolio For Proprietary Position Until At Least 2042
DataMEDS AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx™ artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today...
10-22 19:44
Datameds AI Subsidiary Helomics Receives Medicaid Coverage Determination In Gynecologic Cancers For The ChemoFx Assay In Gynecologic Cancers
DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company vertically integrating its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced t...
10-12 18:04
Reported Earlier: DataMeds AI, Tollo Health Roll Out Health Lives Here Mobile Application
DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, and Tollo Health, LLC ("Tollo"), a heal...
09-29 00:02
DataMeds AI Stock Surges on Mobile App Launch
DataMeds AI Inc. (NASDAQ:MEDS) shares are surging Monday morning following the launch of its "Health Lives Here" mobile application, a joint initiative with Tollo Health and the NFL Alumni Association. Here’s what investors need to know. DataMEDS AI shares are powering higher. Why are MEDS shares ra...
09-28 22:59
DataMeds AI Settles Litigation, Strengthens Balance Sheet
DataMeds AI ( ($MEDS) ) has issued an announcement. On September 11, 2026, Data...
09-18 06:02
DataMEDS AI shares are trading higher after Axe Compute announced the sale of its legacy AI cancer diagnostics laboratory business, Helomics, to DataMEDS in an all‑stock transaction.
DataMEDS AI shares are trading higher after Axe Compute announced the sale of its legacy AI cancer diagnostics laboratory business, Helomics, to DataMEDS in an all‑stock transaction.
09-16 00:44
DataMEDS AI reports Q2 results
DataMEDS AI press release (MEDS): Q2 Net loss per share was $7.13 Revenue was $1.779M in Q2 2026, up 14% sequentially from Q1 2026 and above management projections. More on Wellgistics Health Wellgist...
08-19 15:33
